Researchers analyzing U.S. safety reports say certain medications containing semaglutide may be linked to a rare eye ...

Wegovy may raise the risk of "eye stroke" and vision loss, especially in men, compared to Ozempic due to higher doses of the ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

Wegovy, a GLP-1 agonist for weight loss, may carry the highest risk of "eye stroke" (ischemic optic neuropathy) and sudden sight loss of the semaglutide drugs, finds an analysis of unintended side ...

'Eye strokes' cause sudden and usually permanent vision loss due to reduced blood flow to the optic nerve ...

Orforglipron, which could be approved for obesity next quarter, proved superior at cutting blood sugar and body weight — but at the expense of higher side effect rates.

People with type 2 diabetes had better blood sugar control and more weight loss with orforglipron than with oral semaglutide (Rybelsus) — but also more side effects. For people with type 2 diabetes, ...